Effects of capsicin on the lipids profile in humans with low high density lipoprotein cholesterol levels

The influence of capsicin on high density lipoprotein cholesterol level and function

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-14004605

Enrollment

Unknown

Registered

2014-04-25

Start date

2014-05-12

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dyslipidmia

Interventions

capsicin:3g of pepper powder (including capsicin 6 mg)

placebo:3g of placebo powder (including capsicin 0 mg)

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: fasting serum HDL-C < 1.04 mmol/L, aged 18 to 60 years.

Exclusion criteria

Exclusion criteria: 1. History of serious cardiovascular diseases including myocardial infarction and stroke, liver or kidney dysfunction and tumors; 2. taken any drug that influence blood lipid metabolism.

Design outcomes

Primary

Measure	Time frame
high density lipoprotein cholesterol;	—

Secondary

Measure	Time frame
total cholesterol;low density lipoprotein cholesterol;triglycerid;	—

Countries

China

Contacts

Public ContactMi ManTian

Third Military Medical University

mimt@sina.com+86 23 68752306

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026